Abstract
Hemophilia is a lifelong, chronic disease caused by a deficiency of a clotting factor in the blood. The bleeding episodes caused by that deficiency, especially hemorrhages into the joints, have been the source of pain, suffering, and death to the people who inherited it, from ancient times until just the last half of this century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Addiego, J., Gomperts, E., Gill, J., Hilgartner, M., Abildgaard, C., Parmley, R., Shapiro, A., Andes, A., Krill, C., Werner, E., Aznar, J., Courter, S., & Kingdon, H. (1989, October, 14). Lack of viral transmission in previously untreated hemophiliacs using a monoclonal ab purified, organic solvent/detergent treated plasma derived from factor VIIIc concentrate. In abstracts from the 41st Conference of the National Hemophilia Foundation (p. 1), Chicago, IL.
Agle, D. P. (1975). Psychological factors in hemophilia—the concept of self-care. Annals of the New York Academy of Science, 240, 221–225.
Agle, D., Gluck, H., & Pierce, G. F. (1987). The risk of AIDS: Psychologic impact on the hemophilic population. General Hospital Psychiatry, 9, 11–17.
Aledort, L. M. (1989). Concentrates: meeting the demand. Life Paths, 1(2), 6–7.
Barret, S. (1989, January). Presentation to HIV Risk Reduction within the Hemophilia Community Conference, Las Vegas, NV.
Boyer, P. B. (1989, April 1). A life in limbo. The New York Times Magazine, p. 48.
Centers for Disease Control (1982). Pneumocystis carinii pneumonia among persons with hemophilia A. Morbidity and Mortality Weekly Report, 31, 507.
Centers for Disease Control. (1991, May 8). HIV/AIDS surveillance report, pp. 1-10.
Coles, P. (1989). French haemophiliacs awarded damages. Nature, 340, 253.
Gerety, R. J., & Barker, L. F. (1976). Viral antigens and antibodies in hemophiliacs. In National Heart, Lung, and Blood Institute: Unsolved Therapeutic Problems in Hemophilia (pp. 51–56). Washington, DC: U.S. Government Printing Office.
Gjerset, G. F., McGrady, G., Counts, R. B., Martin, P. J., Jason, J., Kennedy, S., Evatt, B., & Hansen, J. A. (1985). Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate. Blood, 66, 718–720.
Goedert, J. J., Sarngadharan, M. G., Eyster, M. E., Weiss, S. H., Bodner, A. J., Gallo, R. C., & Blattner, W. A. (1985). Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood, 65, 492–495.
Hernandez, J., Gray, D., & Lineberger, H. P. (1989). Social and economic indicators of well-being among hemophiliacs over a 5-year period. General Hospital Psychiatry, 11, 241–247.
Hershgold, E. J., Pool, J. G., & Pappenhagen, A. R. (1966). The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial. Journal of Laboratory and Clinical Medicine, 67, 23–32.
Jason, J., Holman, R. C., Dixon, G., Lawrence, D. N., Bozeman, L. H., Chorba, T. L., Tregillus, L., & Evatt, B. L. (1986). Effects of exposure to factor concentrates containing donations from identified AIDS patients. A matched cohort study. Journal of the American Medical Association, 256, 1758–1762.
Johnson, A. J., Newman, J., Howell, M. B., & Puszkin, S. (1967). Purification of antihemophilic factor (AHF) for clinical and experimental use. Thrombosis, Diathesis, and Haemorrhage, 377-381.
Johnson, J. P., Nair, P., Hines, S. E., Seiden, S. W., Alger, L., Revie, D. R., O’Neil, K. M., & Hebel, R. (1989). Natural history and serologic diagnosis of infants born to human immunodeficiency virus-infected women. American Journal of Diseases of Children, 143, 1147–53.
Kasper, C. K., & Kipnis, S. A. (1972). Hepatitis and clotting factor concentrates. Journal of the American Medical Association, 221, 510.
Kingdon, H. S., Liu, S. L., Bagby, B., Cox, D., Gracien, M., Lee, M., & Courter, S. (1989, October 14). Preliminary result of recombinate™ clinical safety and efficacy. In abstracts from the 41st Conference of the National Hemophilia Foundation (p. 6), Chicago, IL.
Kreiss, J. K., Kitchen, L. W., Prince, H. E., Kasper, C. K., Goldstein, A. L., Naylor, P. H., Preble, O., Stewart, J. A., & Essex, M. (1986). Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study. American Journal of Medicine, 80, 345–350.
Lawrence, D. N., Jason, J. M., Holman, R. C., Heine, P., Evatt, B. L., & the Hemophilia Study Group. (1989). Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic men. American Journal of Hematology, 30, 68–76.
Lawrence, D. N., Jason, J. J., Holman, R. C., Murphy, J. J. (1989, February). Human immunodeficiency virus transmission from hemophilie men to their heterosexual partners. In Proceedings of the CONRAD 2nd International Workshop, Norfolk, VA.
Levine, P. H., & Britten, A. F. H. (1973). Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B. Annals of Internal Medicine, 78, 195–201.
Lusher, J. M. (1989, October 14). Update on safety of clotting factor concentrates. In abstracts from the 41st Conference of the National Hemophilia Foundation (p. 26). Chicago, IL.
Mattsson, A., & Gross, S. (1966). Adaptational and defensive behavior in young hemophiliacs and their parents. American Journal of Psychiatry, 122, 1349–1356.
Mindell, W., O’Neill, R., & French, S. (1989). The social and economic impact of HIV on Canadians with hemophilia. Presented at The Vth International Conference on AIDS, Montreal, Canada.
National Hemophilia Foundation (1988). What you should know about hemophilia. New York: National Hemophilia Foundation.
National Hemophilia Foundation (1989, November 22). MASAC policy on access to AIDS clinical trials. Hemophilia Information Exchange, 97, 1–2.
Overby, K. J., Lo, B., & Litt, I. F. (1989). Knowledge and concerns about acquired immunodeficiency syndrome and their relationship to behavior among adolescents with hemophilia. Pediatrics, 83, 204–210.
Palmer, T. D., Thompson, A. R., & Miller, A. D. (1988, October 15). Recombinant human factor IX in rodents produced by gene transfer. In abstracts from the 40th Conference of the National Hemophilia Foundation (p. 12), Anaheim, CA.
Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C., & Cleary, P. (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 239, 586–592.
Ragni, M. V., Gupta, P., Rinaldo, C. R., Kingsley, L. A., Spero, J. A., & Lewis, J. H. (1988). HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs. Public Health Report, 103, 54–58.
Ragni, M. V., & Nimorwicz, P. (1989). Human immunodeficiency virus transmission and hemophilia. Archives of Internal Medicine, 149, 1379–1380.
Ross, J. (1989). People with hemophilia and HIV. Life Paths, 1, 7–9.
Seeff, L. B., & Hoofnagle, J. (1976). Acute and chronic liver disease in hemophilia. In National Heart, Lung, and Blood Institute: Unsolved therapeutic problems in hemophilia (pp. 61–72). Washington, DC: U.S. Government Printing Office.
Sinclair, R. (1989). The impact on children whose parents or loved ones have HIV disease. Presented at The Vth International Conference on AIDS, Montreal, Canada.
Stehr-Green, J. K., Holman, R. C., Jason, J. M., & Evatt, B. L. (1988). Hemophilia-associated AIDS in the United States, 1981 to September, 1987. American Journal of Public Health, 78, 439–442.
Tetrick, A. P. (1989). Medical insurance policy scrutiny. Guidelines for families with chronic disease. Worcester, MA: New England Hemophilia Center.
Waskin, H., Smith, K. J., Simon, T. L., Gribble, T. J., & Mertz, G. J. (1986). Prevalence of HTLV-III antibody among New Mexico residents with hemophilia. Western Journal of Medicine, 145, 477–480.
Weiss, R. S. (1988). The experience of AIDS: Hypotheses based on pilot study interviews. Journal of Palliative Care, 4, 15–25.
Wilson, P. A., & Wasserman, K. (1989). Psychosocial responses to the threat of HIV exposure among people with bleeding disorders. Health and Social Work, 14, 176–183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wicklund, B.M., Jackson, M.A. (1992). Coping with AIDS in Hemophilia. In: Ahmed, P.I., Ahmed, N. (eds) Living and Dying with AIDS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2347-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2347-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2349-3
Online ISBN: 978-1-4899-2347-9
eBook Packages: Springer Book Archive